AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Biotech’s groundbreaking “Cross-generational Bio-Pulse Exosome Application Platform”, which was awarded the National Innovation Award, can significantly reduce product development time and cost. Leveraging this platform, the company successfully launched Exo Giov in 2021, a cosmetic product harnessing the power of bio-pulsed exosomes for beauty and hair care. Additionally, AM Biotech is in the advanced stages of developing exosome-based treatments for a wide range of diseases, including menopause, ophthalmic disorders, otology, periodontitis, joint diseases, and chronic kidney disease.

Bio-Pulse Activation Technology

AM Biotech’s patented bio-pulse activation technology empowers the company to develop and produce high-quality bio-pulsed exosomes. Compared to conventional exosomes, AM Biotech’s exosomes exhibit significantly enhanced efficacy, with a 202% increase in protein content and a 188% increase in miRNA content. These enhancements make them highly effective in promoting cell repair and tissue regeneration.

Cross-generational Bio-Pulse Exosome Application Platform

This innovative platform is built upon AM Biotech’s patented bio-pulse activation technology and three other core technologies:

Bio-Pulse Activation Technology: Exosomes produced using this technology exhibit several to dozens of times greater efficacy in treating diseases, enhancing beauty, and promoting hair growth compared to conventional exosomes.
High-efficiency exosome production technology: Enables storage at room temperature.
Exosome Ultra-Purification Extraction Technology: Achieves a purity level of 99.99%.
Advanced Mass Production Process: Ensures consistent product quality.

With outstanding R&D achievements and impressive revenue performance, Ascension Medical Biotechnology (AM BioTech) has formed a partnership with the Medical and Pharmaceutical Industry Technology and Development Center (PITDC) to launch multiple biotech projects and enter the trillion-dollar pharmaceutical market 3

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a “Pharmaceutical Project Cooperation Development Agreement.” This collaboration marks the official launch of several biotech and pharmaceutical development projects, as AM BioTech ventures into the trillion-dollar pharmaceutical market.

Leveraging its exclusive international patent for bio-pulsed technology, AM BioTech has applied this innovation to various medical and cosmetic research areas. The first commercial product utilizing this technology is ExoGiov, the world’s first exosome designed specifically for skin rejuvenation and hair growth. Unlike non-induced exosomes (Naive Exosomes), ExoGiov has achieved international recognition with an INCI certification in 2022. Its remarkable effectiveness, unique market position, and ease of use have led to significant revenue growth. The product, available in lyophilization powder, liquid, and skincare formulations, can be stored at room temperature, reflecting the company’s impressive performance within just three years of its establishment.

Dr. Richard Hsieh, Chairman of AM BioTech, stated that in addition to its applications in beauty and hair growth, the bio-pulsed technology is also being explored for potential pharmaceutical uses in obstetrics and gynecology, dentistry, ophthalmology, nephrology, orthopedics, otolaryngology, and major wound repair. Preclinical efficacy tests have been completed, and most animal trials are finalized, showing promising potential to address unmet medical needs in these fields. The company is actively positioning its international patents and will soon publish four international research papers.

Ensuring legal compliance and product development in both beauty and pharmaceutical sectors remains a core principle for AM BioTech. The company will adhere to international pharmaceutical regulations as it embarks on developing medical projects. The PITDC, renowned for its expertise in pharmaceutical development and regulatory affairs, will collaborate closely with AM BioTech. After extensive discussions and planning between both teams, the agreement will officially commence in September 2024. This partnership signifies a new milestone for AM BioTech as it enters the biotech pharmaceutical development arena.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a “Pharmaceutical Project Cooperation Development Agreement.” This collaboration marks the official launch of several biotech and pharmaceutical development projects, as AM BioTech ventures into the trillion-dollar pharmaceutical market.

Dr. Mu-Huan Su, Chairman of the PITDC, emphasized that the center’s mission is to assist domestic companies with pharmaceutical product development and guidance while facilitating communication among industry, government, academia, and research sectors. This approach aims to enhance the technical standards of the pharmaceutical industry, promote technological advancement, and achieve industry upgrading and internationalization. The PITDC and AM BioTech have been discussing this project for three years, focusing on pharmaceutical initiatives. Given Taiwan’s relatively small market, it can be challenging for local industries to invest in such R&D. However, AM BioTech’s commitment to substantial research in new indications and applications is highly commendable. This collaboration will not only upgrade but also internationalize Taiwan’s industry. We aim to accelerate AM Biotech’s key pharmaceutical ingredients, product development and launch by partnering with the PITDC research team. Our collaboration will address both domestic and international regulations, enhance quality management systems, and implement manufacturing technologies. This will reduce the risks of AM Biotech’s self-funded development, shorten time to market, and speed up integration into the international supply chain. The planned development will proceed in two stages, aiming to maximize the benefits of domestically produced high-value pharmaceutical products.

Dr. Richard Hsieh, Chairman of AM BioTech, concluded by expressing confidence that, with the combined efforts of both teams, preliminary results will soon be visible, and the commercialization of pharmaceutical products will follow. AM BioTech’s research achievements and patent strategy are well-planned, offering a competitive market advantage. With the PITDC’s support and the collaborative development plan, the launch of AM BioTech’s products in various pharmaceutical applications is anticipated to be imminent.

Read Moreread more

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre

2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

Exhibition Dates: July 25 to July 28, 2024
Exhibition Hours: 10:00 AM – 6:00 PM daily (until 5:00 PM on the last day)
Exhibition Venue: Nangang Exhibition Center, Hall 1, 1st Floor, Zone K (No. 1, Jingmao 2nd Road, Nangang District, Taipei City)
Booth Numbers: K622, K624

Biotechnology ✕ Beauty and Health “Asia Healthcare & Medical Cosmetology Expo 2024” showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting our exclusive “Bio-Pulsed” patented technology, scientifically backed beauty and hair care ingredient ExoGiov® Bio-Pulsed Exosomes, and eagerly anticipated new products.

AM Biotech’s Core Technologies

• Exclusive Bio-Pulsed Patent Technology
• Cutting-Edge Manufacturing Process for Mass Production
• Ultra-Purification Extraction Technology for Exosomes
• High-Efficiency Exosome Production Technology for Room Temperature Storage

Advantages of ExoGiov® Bio-Pulsed Exosome Ingredients

• Smooth Wrinkles, Tighten Skin: Promotes the growth of skin-related fibroblasts, anti-inflammation, collagen, and elastin production, with effects 10 to 16 times higher than ordinary exosomes.
• Brighten Skin, Even Out Skin Tone: Degrades melanin miRNA, hundreds of times more effective than ordinary exosomes.
• Strengthen Hair Roots, Revitalize Scalp: Promotes and activates follicle cell growth, with effects 5 to 6 times higher than ordinary exosomes.

Read Moreread more

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre

2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.

The kidneys play a critical role in filtering metabolic waste, regulating blood pressure, and maintaining the balance of fluids, electrolytes, and pH in our bodies. However, the onset of chronic illnesses such as diabetes, hypertension, and gout, or the improper use of medication, can lead to CKD. The progression of CKD is slow, often leaving the kidneys in a compromised state for extended periods, which can lead to renal fibrosis—a condition where the kidneys become scarred—and gradually result in a decline in kidney function. Eventually, this may advance to end-stage renal disease (ESRD), at which point most patients require dialysis or a kidney transplant.

A promising avenue for treating CKD, particularly in reducing renal fibrosis, involves the use of engineered extracellular vesicles. These vesicles encapsulate a protein known as CHIP (Carboxyl terminus of Hsp70 Interacting Protein), which plays a crucial role in protein management within cells.

In groundbreaking research highlighted in npj Regenerative Medicine, scientists conducted a study where CHIP-encapsulated extracellular vesicles were administered intravenously to rats that had undergone unilateral ureteral obstruction surgery to induce CKD. This surgery blocks one of the tubes that carries urine from the kidney to the bladder, simulating kidney conditions in humans.

After 14 days of treatment, the rats showed a significant reduction in kidney fibrosis. This result points to a potential non-invasive treatment option that could substantially alter the management of CKD and its progression to more severe stages. This innovative approach not only offers new hope for patients with chronic kidney conditions but also exemplifies the power of advanced biotechnological interventions in regenerative medicine.

Post-UUO Surgery Impact on Renal Fibrosis Treated with Exosomes

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

“Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

AM BIOTECH is the exhibitor at In-cosmetics Global (Paris, France from April 16 to April 18, 2024) for its patented Bio-pulsed Exosomes (Extracellular Vesicles) raw materials and related derivatives products. In-cosmetics Global is a leading international cosmetics tradeshow annually for worldwide network of personal care ingredients and cosmetic ingredient; the exhibition displays the best achievements in the global cosmetics industry and can be called the “Oscars Global event for the cosmetics industry”. For personal care & cosmetics ingredients exhibitors, suppliers & manufactures included outstanding top cosmetic raw material suppliers such as BASF, Croda, Ashland, Solvay, Evonik, etc., exhibiting their new generation of innovative cosmetic raw materials. Leading international cosmetics brands and manufacturers such as L’Oreal, Unilever, Procter & Gamble, Estee Lauder, Kenvue, LVMH, etc. they are looking for excellent innovative cosmetic raw materials that comply with international regulations as a new generation of cutting-edge cosmetics for development and application.

ExoGiov® is a Biochemical-pulsed exosome; developed by AM BIOTECH; specifically designed for facial beauty and hair health. It is a specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, which is complies with international standards and regulations acceptable worldwide (INCI: chicken embryonic mesenchymal cell-derived extracellular vesicles). The Bio-pulsed exosome with inducing activated function is a self-developed patented cosmetic ingredient in combined the key 4 pillars innovation of (Clinical breakthroughs, Product innovation, Ingredient innovation, Research and Biotechnology innovation); its excellent efficacy results surpass ordinary exosomes and common cosmetic ingredients. The results and efficacy data were also published in the international Journal of Molecular Science.

AM BIOTECH Biochemical-pulsed exosome was selected as one of the top five innovation cosmetics raw materials in the world at 2024 in-cosmetics Global by the Estée Lauder Company’s New Incubation Ventures (NIV) BRKTHRU VOICES Prize. Hence, it is not only AM BIOTECH has the honor with international affirmation in advance medical research & innovation; but also, the opportunity to expand the worldwide market internationally for ExoGiov® Biochemical Pulsed Exosomes in important professional facial beauty & haircare channels.

Dr. Richard Hsieh, Chairman and Founder of AM BIOTECH for his leading Biochemical Pulse Exosomes, he particularly emphasized that exosome manufacturers around the world are planning for globalization in the international market, and AM BIOTECH is no exception. Although South Korea, Japan and even Taiwan have opened to use human Cell-derived exosomes for cosmetic raw materials, but in order to be able to integrate with the international market, so that the products can go out of Taiwan and take a global view, they must comply with the cosmetics regulations of most mainstream international markets. It can be seen that there is no company that used human-derived exosomes has joined the 2024 In-cosmetics Global exhibition.

AM BIOTECH ExoGiov® exosome complies with international standards and regulations acceptable worldwide, which is specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, and the others ordinary exosomes are mostly plant-derived exosomes. Furthermore, ExoGiov® is the world’s only Bio-pulsed exosome raw material for inducing facial beauty and hair growth functions.

This innovation breakthrough is the core of ExoGiov® patented biochemical pulsed functional-inducing-exosome technology, it can precisely regulate the expression of miRNA genes to make it better than ordinary Exosomes and general cosmetic raw materials. The effectiveness of ExoGiov® are dozens of times more effective in facial beauty and hair health, such as collagen type I and type III, elastin, skin fibroblast proliferation, melanin degradation, and hair follicle cell proliferation. It has produced excellent results in all aspects.

AM BIOTECH’s latest research on promoting hair follicle cell proliferation, it was further found that Minoxidil (the active ingredient of Rogaine) has an 87% hair follicle cell proliferation rate and a 20% hair follicle cell proliferation rate with generally non-functional inducing exosomes. The hair follicle cell proliferation rate of AM BIOTECH BIO-Pulsed Exosomes is 113%, and its efficacy is very outstanding.

AM BIOTECH Bio-Pulsed Exosomes has innovation break through on this cosmetic application, the storage and the regulation limitation. ExoGiov® patented biochemical pulsed functional-inducing-exosome has the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature, they comply with the international cosmetic regulations and banning exosomes derived from human cells in most countries. The exosomes are the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature.Most of the exosomes currently on the market are need to be keep in frozen temperature or refrigerated in low temperature to ensure bioactivity, their application in the development and application of cosmetic products is very limited.

AM BIOTECH entered into the top five finalist’s breakthrough innovation cosmetics raw materials in the world for the Estée Lauder (NIV) BRKTHRU VOICES Prize at 2024 In-cosmetics Global. ExoGiov® BIO-Pulsed Exosomes demonstrates its development advantages in the international market, the Estée Lauder (NIV) Executive Officer Mr. Ryan J. Piela and his expert team also saw these advantages and characteristics of AM BIOTECH Biochemical-Pulsed Exosomes. This professional recognition from Estée Lauder company has also prompted many other international cosmetics brands and cosmetics ingredients distributor agents from various international countries to inquire about AM BIOTECH the exosomes business cooperation.

AM BIOTECH becomes the first Taiwan’s exosomes to enter the international market, the Glory of Taiwan.  AM BIOTECH has officially launched the ExoGiov® Bio-pulsed exosomes in use and application in the cosmetics ingredient and LA EXO® related skincare & haircare products.

Read Moreread more

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre

2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

Hearing loss is a prevalent and often underestimated global health issue affecting people of all ages. According to the World Health Organization’s “World Report on Hearing,” as of 2021, about one-fifth of the global population suffers from hearing impairment, a figure projected to rise to one-quarter by 2050.

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by nerves. Damage to these cochlear hair cells and nerves can lead to permanent hearing impairment.

The cochlea contains a structure similar to the blood-brain barrier, known as the blood-labyrinth barrier (BLB), which prevents many large molecular drugs from treating the hair cells and cochlear nerves. However, advancements in nanotechnology within biomedical research have identified a type of nanoparticle—exosomes—that can potentially cross this barrier to treat hair cells and nerves.

The focus of this recent study is on exosomes wrapped with Brain-Derived Neurotrophic Factor (BDNF), which are used to aid in the repair of cochlear hair cells and nerves:

Researchers first isolated exosomes and encapsulated them with BDNF (referred to as BDNF-sEV). They then conducted animal experiments where mice were given BDNF-sEV through intravenous injections. The mice were subsequently exposed to a noisy environment to induce hearing loss, followed by another injection of BDNF-sEV.

After 14 days, the condition of the cochlear hair cells and nerves in the mice was assessed. The results showed that the mice’s hair cells and nerves were severely damaged after noise exposure. However, post-treatment with BDNF-sEV, the cochlear hair cells and nerves showed significant repair.

This study demonstrates the potential of exosomes in preventing and repairing hearing damage. Recent research also indicates that exosomes have performed well in nerve repair, suggesting that they could provide new hope for future clinical applications.

Under noise exposure, the condition of exosomes in preventing and repairing damaged hair cells. (Edit by AM Biotech study team)

Under noise exposure, the condition of exosomes in preventing and repairing damage to cochlear nerves. (Edit by AM Biotech study team)

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

Osteoporosis, often dubbed the “silent thief,” stealthily compromises bone strength without noticeable symptoms, leaving many individuals unaware of their condition. This disease predominantly affects high-risk groups such as postmenopausal women, leading to postmenopausal osteoporosis, and the elderly, who face senile osteoporosis due to chronic bone loss.

Under normal conditions, skeletal muscles release humoral factors that regulate bone metabolism, ensuring a balance in bone density. This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors.

The research team embarked on isolating these humoral factors to extract the contained exosomes, known as Myo-EVs. In a series of animal experiments, diabetic mice were treated with Streptozotocin (STZ) to induce a state of bone imbalance and hinder bone repair. The mice’s femurs were then precisely drilled with a 0.8 mm hole to observe the healing process.

Remarkably, just 9 days post-treatment, mice administered with Myo-EVs exhibited significant bone cell regeneration. Gene analysis further revealed an increase in bone-forming genes within the bone cells of these Myo-EV-treated mice. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Mouse Femur Defect Repair Test

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

Male pattern baldness, a widespread hair condition, affects millions globally. Its primary cause is linked to the increased scalp levels of a male hormone known as dihydrotestosterone (DHT). DHT’s interaction with hair follicle receptors leads to the thinning and eventual loss of hair.

Current treatments mainly involve topical Minoxidil applications and oral Finasteride doses. Despite their popularity, these solutions don’t guarantee success and have been associated with side effects in some cases.

The prevailing theory suggests that DHT triggers hair loss by activating a specific signaling pathway called “TGF-β1/SMAD3” in the body. This pathway is intricately connected to a series of biochemical reactions leading to “cell apoptosis” or cell death.

Recent research highlights a groundbreaking discovery: the microRNA “miR-122-5p” within stem cell exosomes. This particular microRNA can neutralize the excessive activation of TGF-β1/SMAD3 caused by DHT, offering a protective shield for hair follicle cells against apoptosis.

Animal studies underscore the potential of stem cell exosomes enriched with miR-122-5p in combating male pattern baldness, paving the way for optimistic future clinical applications.

As the exploration of exosomes in clinical settings progresses, there’s growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss therapy.

Observing Hair Regrowth in Mice Post-Depilation

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

Stem cell exosomes have the potential to be used in medical aesthetics to aid in skin repair and regeneration, but did you know that exosomes might also be applied in eye treatments?

A recent study published in Science Advances in 2022 discovered that exosomes can alleviate the side effects of dry eye syndrome caused by GVHD (Graft Versus Host Disease), one of the main complications after transplantation. Mild GVHD can affect the quality of life of patients, while severe GVHD can threaten long-term survival.

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation. This leads to a disorder in the ocular immune microenvironment, ultimately resulting in cell apoptosis and worsening eye tissue damage. The effectiveness of current clinical drugs in treatment is limited, and some patients with severe conditions face a lack of effective treatment options.

In a prospective clinical trial, mesenchymal stem cell exosomes (MSC-exo) used as eye drops inhibited inflammation and improved epithelial recovery, showing significant therapeutic effects in both mice and humans. Symptoms of dry eye, including stinging, burning, and redness, were alleviated after treatment, with effects surpassing those of artificial tears. For corneas damaged by inflammation, exosome treatment protected corneal structure through mechanisms such as preventing corneal epithelial degeneration, reducing pro-inflammatory gene expression, and converting M1 pro-inflammatory macrophages into M2 anti-inflammatory macrophages.

This research data further supports the potential of exosomes as a component in the treatment of eye diseases, promising to become the next target for drug development.

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.